Home >> Tag Archives: Oncomatrix—

Tag Archives: Oncomatrix—

IHC-based kit for tumor invasiveness, 4/13:88

Oncomatrix’s DMTXinvaScan is an immunohistochemistry-based kit designed to diagnose and predict the invasiveness of pancreas, breast, lung, colon, and head and neck tumors. The main component of DMTXinva-Scan is a monoclonal antibody that detects collagen XI-α1. Oncomatrix developed and clinically validated this antibody.

Read More »